Ropizine
- Level
- Commodity
- Parent
- 51141500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51141577This classification denotes an anticonvulsant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q5128GW9D4. European Medicines Agency schedules Ropizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10383MIG. Ropizine generally arises in the molecular formula C24H26N4. The term ROPIZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 no. 2 1999, list 40.) ROPIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ropizine under HS 29335995 and SITC 51576. As of Q4 2014, ROPIZINE remains the US FDA Preferred Term for this commodity. Ropizine bears US NLM identifiers UMLS ID C0073572 and NCI Concept Code C75166. SMILES: N1(C(C2CCCCC2)C2CCCCC2)CCN(/N=C/C2NC(CCC2)C)CC1.
Same parent
Under 51141500 · 80Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.